Nakiller Listesi

Filter by:

No. Cell source Indication Area of medicine Year Type of therapy Country Age
1 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 2.2
2 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 5.4
3 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 10.3
4 autologous cord blood autism neurology 2017 experimental therapy Poland 4.1
5 autologous cord blood autism neurology 2016 experimental therapy Poland 6.0
6 autologous cord blood cerebral ischemia neurology 2008 experimental therapy Poland 1.5
7 cord blood CD40 ligand deficiency hematology 2017 standard therapy Turkey 9.6
8 cord blood talassemia major hematology 2017 standard therapy Turkey 4.0
9 cord blood talassemia major hematology 2017 standard therapy Turkey 4.1
10 cord blood relapse of acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7.3
11 cord blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6.0
12 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7.0
13 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4.0
14 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7.0
15 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3.0
16 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3.0
17 cord blood beta-talassemia; agranulocytosis hematology 2013 standard therapy Turkey 8.0
18 cord blood X - linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10.1
19 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3.0
20 cord blood anaemia talassemia major hematology 2012 standard therapy Turkey 6.0
21 cord blood talassemia major acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 3.5
22 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5.0
23 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12.0
24 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2.0
25 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5.0
26 cord blood histiocytosis hematology 2011 standard therapy Poland 2.5
27 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 7.5
28 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 1.5
29 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5.0
30 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5.0
31 cord blood neuroblastoma hematology 2007 standard therapy Poland 8.0
32 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 2,10
33 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 67,11
34 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 37,9
35 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,7
36 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 0.0
37 cord tissue autism neurology 2017 experimental therapy Poland 7,11
38 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 47,6
39 cord tissue spinocerebellar ataxia neurology 2017 experimental therapy Poland 44,1
40 cord tissue spinal cord injury orthopedics 2017 experimental therapy Poland 34,11
41 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 58,10
42 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,0
43 cord tissue Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,4
44 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 37,7
45 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 26,11
46 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
47 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,11
48 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,3
49 cord tissue cartilage damage orthopedics 2017 experimental therapy Poland 61,5
50 cord tissue spinal cord injury orthopedics 2017 experimental therapy Poland 34,1
51 cord tissue sclerosis multiplex neurology 2017 experimental therapy Poland 52,9
52 cord tissue atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 23,9
53 cord tissue Stargardt's disease ophthalmology 2017 experimental therapy Poland 31,6
54 cord tissue age-related macular degeneration ophthalmology 2017 experimental therapy Poland 33,4
55 cord tissue tetraparesis spastica neurology 2017 experimental therapy Poland 29,4
56 cord tissue spinal cord injury orthopedics 2017 experimental therapy Poland 24,9
57 cord tissue spinal muscular atrophy neurology 2017 experimental therapy Poland 10,6
58 cord tissue Stargardt's disease ophthalmology 2017 experimental therapy Poland 30,0
59 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 56,8
60 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,2
61 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45,9
62 cord tissue dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,6
63 cord tissue limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 44,2
64 cord tissue spinal muscular atrophy neurology 2017 experimental therapy Poland 41,4
65 cord tissue limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 25,8
66 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 75,9
67 cord tissue Stargardt's disease ophthalmology 2017 experimental therapy Poland 23,7
68 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,4
69 cord tissue optic atrophy ophthalmology 2017 experimental therapy Poland 39,0
70 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
71 cord tissue spinal cord injury orthopedics 2017 experimental therapy Poland 39,0
72 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 42,11
73 cord tissue optic atrophy ophthalmology 2017 experimental therapy Poland 30,9
74 cord tissue spinal muscular atrophy neurology 2017 experimental therapy Poland 12,11
75 cord tissue spinal muscular atrophy neurology 2017 experimental therapy Poland 8,5
76 cord tissue gonarthrosis orthopedics 2017 experimental therapy Poland 58,9
77 cord tissue cri du chat syndrome neurology 2017 experimental therapy Poland 8,6
78 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 18,7
79 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,8
80 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 22,1
81 cord tissue dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,11
82 cord tissue epilepsia neurology 2017 experimental therapy Poland 3,1
83 cord tissue cranium bifidum neurology 2017 experimental therapy Poland 5,2
84 cord tissue transverse myelitis neurology 2017 experimental therapy Poland 8,3
85 cord tissue syringomielia neurology 2017 experimental therapy Poland 42,6
86 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,9
87 cord tissue sclerosis multiplex neurology 2017 experimental therapy Poland 47,2
88 cord tissue limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 38,5
89 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
90 cord tissue autism neurology 2017 experimental therapy Poland 13,4
91 cord tissue encephalopathy neurology 2017 experimental therapy Poland 21,10
92 cord tissue encephalopathy neurology 2017 experimental therapy Poland 5,0
93 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 41,0
94 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,1
95 cord tissue cerebral palsy; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 1,9
96 cord tissue autism neurology 2017 experimental therapy Poland 11,11
97 cord tissue limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 26,10
98 cord tissue autism neurology 2017 experimental therapy Poland 9,1
99 cord tissue cerebellar syndrome neurology 2017 experimental therapy Poland 11,5
100 cord tissue congenital fiber-type disproportion myopathy neurology 2017 experimental therapy Poland 1,10
101 cord tissue chronic myeloid leukemia hematology 2017 experimental therapy Poland 5,11
102 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,5
103 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 40,11
104 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48,1
105 cord tissue spina bifida neurology 2017 experimental therapy Poland 1,11
106 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 37,11
107 cord tissue arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 1,7
108 cord tissue encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 4,4
109 cord tissue cerebral palsy; epilepsy neurology 2017 experimental therapy Poland 5,8
110 cord tissue spinal cord injury orthopedics 2017 experimental therapy Poland 6,4
111 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 15,4
112 cord tissue traumatic brain injury neurology 2017 experimental therapy Poland 9,4
113 cord tissue no bone adhesion orthopedics 2017 experimental therapy Poland 14,1
114 cord tissue no bone adhesion orthopedics 2017 experimental therapy Poland 17,11
115 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 69,10
116 cord tissue spinal muscular atrophy neurology 2017 experimental therapy Poland 24,9
117 cord tissue optic atrophy ophthalmology 2017 experimental therapy Poland 37,7
118 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,1
119 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,11
120 cord tissue Stargardt's disease ophthalmology 2017 experimental therapy Poland 27,11
121 cord tissue Stargardt's disease ophthalmology 2017 experimental therapy Poland 45,4
122 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 34,10
123 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 31,6
124 cord tissue hydrocephalus; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 2,3
125 cord tissue autism neurology 2017 experimental therapy Poland 6,3
126 cord tissue autism neurology 2017 experimental therapy Poland 7,11
127 cord tissue delayed psychomotor development neurology 2017 experimental therapy Poland 3,5
128 cord tissue delayed psychomotor development neurology 2017 experimental therapy Poland 6,3
129 cord tissue syndrom IFAP hematology 2017 experimental therapy Poland 3,5
130 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 52,0
131 cord tissue acute graft versus host disease hematology 2017 experimental therapy Poland 13,0
132 cord tissue acute graft versus host disease hematology 2017 experimental therapy Poland 11,10
133 cord tissue optic atrophy ophthalmology 2017 experimental therapy Poland 66,11
134 cord tissue ischemia within the optic nerve ophthalmology 2017 experimental therapy Poland 37,11
135 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,1
136 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 4,11
137 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 77,2
138 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36,11
139 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 63,11
140 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,6
141 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,9
142 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 31,9
143 cord tissue autism neurology 2017 experimental therapy Poland 10,2
144 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 33,5
145 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 5,7
146 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 12,5
147 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 5,9
148 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 3,3
149 cord tissue delayed psychomotor development neurology 2017 experimental therapy Poland 5,0
150 cord tissue hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1,9
151 cord tissue Krabbe disease neurology 2017 experimental therapy Poland 6,3
152 cord tissue spinocerebellar ataxia neurology 2017 experimental therapy Poland 24,6
153 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
154 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 45,5
155 cord tissue optic atrophy ophthalmology 2017 experimental therapy Poland 31,5
156 cord tissue Stargardt's disease ophthalmology 2017 experimental therapy Poland 48,10
157 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 62,5
158 cord tissue cerebellar syndrome neurology 2017 experimental therapy Poland 60,5
159 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 6,1
160 cord tissue autism neurology 2017 experimental therapy Poland 4,8
161 cord tissue spina bifida neurology 2017 experimental therapy Poland 6,4
162 cord tissue spina bifida neurology 2017 experimental therapy Poland 6,3
163 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,0
164 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,1
165 cord tissue condition after encephalitis neurology 2017 experimental therapy Poland 19,7
166 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 35,4
167 cord tissue spina bifida neurology 2017 experimental therapy Poland 1,10
168 cord tissue autism neurology 2017 experimental therapy Poland 6,8
169 cord tissue encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 1,5
170 cord tissue autism neurology 2017 experimental therapy Poland 7,0
171 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 13,6
172 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 6,7
173 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 32,3
174 cord tissue sclerosis multiplex neurology 2017 experimental therapy Poland 46,9
175 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,10
176 cord tissue dystrophia myotonica neurology 2017 experimental therapy Poland 41,11
177 cord tissue global developmental delay neurology 2017 experimental therapy Poland 4,7
178 cord tissue optic neuropathy ophthalmology 2017 experimental therapy Poland 56,4
179 cord tissue spina bifida neurology 2017 experimental therapy Poland 4,1
180 cord tissue spina bifida neurology 2017 experimental therapy Poland 3,6
181 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 33,4
182 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 42,1
183 cord tissue acute graft versus host disease hematology 2017 experimental therapy Poland 2,4
184 cord tissue optic neuropathy ophthalmology 2017 experimental therapy Poland 30,11
185 cord tissue optic atrophy ophthalmology 2017 experimental therapy Poland 39,7
186 cord tissue autism neurology 2017 experimental therapy Poland 4,8
187 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 8,2
188 cord tissue spina bifida neurology 2017 experimental therapy Poland 3,4
189 cord tissue spina bifida neurology 2017 experimental therapy Poland 2,11
190 cord tissue delayed psychomotor development neurology 2017 experimental therapy Poland 7,9
191 cord tissue arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 3,5
192 cord tissue dystrophia myotonica neurology 2017 experimental therapy Poland 3,2
193 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63,2
194 cord tissue optic atrophy ophthalmology 2017 experimental therapy Poland 76,10
195 cord tissue dystrophia progressiva pseudohypertrophica /BMD neurology 2017 experimental therapy Poland 23,9
196 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 3,7
197 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 43,8
198 cord tissue optic neuropathy ophthalmology 2017 experimental therapy Poland 74,5
199 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,7
200 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
201 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 70,11
202 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 65,1
203 cord tissue encephalopathy neurology 2017 experimental therapy Poland 5,5
204 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 8,4
205 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 15,1
206 cord tissue spina bifida neurology 2017 experimental therapy Poland 5,8
207 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
208 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 12,10
209 cord tissue retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 26,9
210 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 18,4
211 cord tissue autism neurology 2017 experimental therapy Poland 10,8
212 cord tissue autism neurology 2017 experimental therapy Poland 13,1
213 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 7,9
214 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 5,5
215 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 3,7
216 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 3,5
217 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 5,1
218 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 3,4
219 cord tissue Devic’s disease neurology 2017 experimental therapy Poland 45,2
220 cord tissue limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 31,3
221 cord tissue spina bifida neurology 2017 experimental therapy Poland 6,10
222 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 5,3
223 cord tissue epilepsia autism neurology 2017 experimental therapy Poland 6,0
224 cord tissue myopathy of congenital fiber type disproportion; damage to the central nervous system neurology 2017 experimental therapy Poland 2,2
225 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 2,7
226 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 68,1
227 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,3
228 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 49,1
229 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 60,1
230 cord tissue global developmental delay neurology 2017 experimental therapy Poland 7,11
231 cord tissue spina bifida neurology 2017 experimental therapy Poland 2,8
232 cord tissue autism neurology 2017 experimental therapy Poland 4,11
233 cord tissue muscular dystrophy neurology 2017 experimental therapy Poland 10,8
234 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
235 cord tissue sclerosis multiplex neurology 2017 experimental therapy Poland 38,0
236 cord tissue sclerosis multiplex neurology 2017 experimental therapy Poland 25,2
237 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 58,7
238 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 3,2
239 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 4,7
240 cord tissue autism neurology 2017 experimental therapy Poland 4,8
241 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63,0
242 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 62,9
243 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 57,9
244 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,11
245 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,5
246 cord tissue amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 53,9
247 cord tissue leukodystrophy neurology 2017 experimental therapy Poland 7,1
248 cord tissue atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 35,5
249 cord tissue epilepsia neurology 2017 experimental therapy Poland 16,4
250 cord tissue spinal cord injury orthopedics 2017 experimental therapy Poland b/d
251 cord tissue tetraparesis orthopedics 2017 experimental therapy Poland 27,11
252 cord tissue acute graft versus host disease hematology 2017 experimental therapy Poland 8,10
253 cord tissue epilepsia neurology 2017 experimental therapy Poland 9,11
254 cord tissue cerebral palsy neurology 2017 experimental therapy Poland 4,11
255 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 10,11
256 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
257 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
258 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32,2
259 cord tissue spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
260 cord tissue spinocerebellar ataxia neurology 2016 experimental therapy Poland 62,5
261 cord tissue autism neurology 2016 experimental therapy Poland 18,4
262 cord tissue dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 48,8
263 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 10,3
264 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35,3
265 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,7
266 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 12,2
267 cord tissue delayed psychomotor development neurology 2016 experimental therapy Poland 3,10
268 cord tissue acute graft versus host disease hematology 2016 experimental therapy Poland 14
269 cord tissue acute graft versus host disease hematology 2016 experimental therapy Poland 6
270 cord tissue gonarthrosis orthopedics 2016 experimental therapy Poland 65,8
271 cord tissue leukodystrophy neurology 2016 experimental therapy Poland 2,9
272 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,4
273 cord tissue autism neurology 2016 experimental therapy Poland 6
274 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 2,11
275 cord tissue autism neurology 2016 experimental therapy Poland 12,11
276 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 9,7
277 cord tissue atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,3
278 cord tissue Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
279 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 33,5
280 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 22,2
281 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 10,3
282 cord tissue autism neurology 2016 experimental therapy Poland 8,5
283 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 29,11
284 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,4
285 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37,4
286 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,3
287 cord tissue autism neurology 2016 experimental therapy Poland 7,11
288 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 28
289 cord tissue gonarthrosis orthopedics 2016 experimental therapy Poland 69,6
290 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 33,11
291 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 20,7
292 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 24,5
293 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 25,6
294 cord tissue autism neurology 2016 experimental therapy Poland 8,5
295 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39,10
296 cord tissue patella cartilage damage orthopedics 2016 experimental therapy Poland 60,10
297 cord tissue autism neurology 2016 experimental therapy Poland 6,9
298 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 44,8
299 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25,4
300 cord tissue autism neurology 2016 experimental therapy Poland 10,10
301 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 63,2
302 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,11
303 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,9
304 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,9
305 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
306 cord tissue chronic graft versus host disease hematology 2016 experimental therapy Poland 19,2
307 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
308 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
309 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,7
310 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,6
311 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,11
312 cord tissue tetraparesis spastica orthopedics 2016 experimental therapy Poland 28,8
313 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,9
314 cord tissue spinal muscular atrophy neurology 2016 experimental therapy Poland 34,9
315 cord tissue gonarthrosis orthopedics 2016 experimental therapy Poland 69,3
316 cord tissue tetraparesis spastica orthopedics 2016 experimental therapy Poland 47,9
317 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 18,8
318 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 2,9
319 cord tissue traumatic brain injury neurology 2016 experimental therapy Poland 54,9
320 cord tissue epilepsia neurology 2016 experimental therapy Poland 19,5
321 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
322 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,9
323 cord tissue tetraparesis orthopedics 2016 experimental therapy Poland 27,9
324 cord tissue epilepsia neurology 2016 experimental therapy Poland 14,9
325 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42,7
326 cord tissue acute graft versus host disease hematology 2016 experimental therapy Poland 60,5
327 cord tissue autism neurology 2016 experimental therapy Poland 6,2
328 cord tissue autism neurology 2016 experimental therapy Poland 11,3
329 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 9,11
330 cord tissue gonarthrosis orthopedics 2016 experimental therapy Poland 49,8
331 cord tissue optic atrophy ophthalmology 2016 experimental therapy Poland 69,9
332 cord tissue optic atrophy ophthalmology 2016 experimental therapy Poland 69,1
333 cord tissue epilepsia neurology 2016 experimental therapy Poland 13,11
334 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 45.1
335 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53.4
336 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 36.1
337 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59, 1
338 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.2
339 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49.7
340 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.1
341 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46.1
342 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72.4
343 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54.3
344 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56.1
345 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61.8
346 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64.7
347 cord tissue malformation syndrome neurology 2016 experimental therapy Poland 3,5
348 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,2
349 cord tissue retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
350 cord tissue autism neurology 2016 experimental therapy Poland 6,10
351 cord tissue encephalopathy neurology 2016 experimental therapy Poland 2,11
352 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,8
353 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,5
354 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,3
355 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 4,2
356 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 55,4
357 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 54,8
358 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,10
359 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 41,4
360 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 49,3
361 cord tissue choroideremia ophthalmology 2016 experimental therapy Poland 50,8
362 cord tissue retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63,1
363 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 7,4
364 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,4
365 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 73,7
366 cord tissue leukodystrophy neurology 2016 experimental therapy Poland 2,11
367 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,6
368 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 48,3
369 cord tissue retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32,7
370 cord tissue acute graft versus host disease hematology 2016 experimental therapy Poland 3,11
371 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 61,11
372 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 45,8
373 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,4
374 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 79,2
375 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,6
376 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,4
377 cord tissue adrenoleukodystrophy neurology 2016 experimental therapy Poland 6,11
378 cord tissue adrenoleukodystrophy neurology 2016 experimental therapy Poland 9,7
379 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,2
380 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50,9
381 cord tissue limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
382 cord tissue epilepsia neurology 2016 experimental therapy Poland 14,7
383 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
384 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,6
385 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 58,10
386 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 12,6
387 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
388 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
389 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,4
390 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,7
391 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58.1
392 cord tissue spina bifida neurology 2016 experimental therapy Poland 4.8
393 cord tissue spina bifida neurology 2016 experimental therapy Poland 1.5
394 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 3.0
395 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 9.9
396 cord tissue global developmental delay neurology 2016 experimental therapy Poland 6.9
397 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.8
398 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39.6
399 cord tissue autism neurology 2016 experimental therapy Poland 13.2
400 cord tissue developmental delay neurology 2016 experimental therapy Poland 7.4
401 cord tissue spina bifida neurology 2016 experimental therapy Poland 7.4
402 cord tissue optic neuropathy ophthalmology 2016 experimental therapy Poland 66.0
403 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 38.1
404 cord tissue autism neurology 2016 experimental therapy Poland 8.4
405 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 3.0
406 cord tissue optic neuropathy ophthalmology 2016 experimental therapy Poland 79,8
407 cord tissue spinocerebellar ataxia neurology 2016 experimental therapy Poland 54,3
408 cord tissue dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 14,4
409 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 47,11
410 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
411 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
412 cord tissue retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 23.6
413 cord tissue age-related macular degeneration ophthalmology 2016 experimental therapy Poland 86.5
414 cord tissue retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 54.6
415 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 68,5
416 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 13,7
417 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 2,2
418 cord tissue autism neurology 2016 experimental therapy Poland 5,0
419 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 12,11
420 cord tissue autism neurology 2016 experimental therapy Poland 12,3
421 cord tissue spina bifida neurology 2016 experimental therapy Poland 1,3
422 cord tissue developmental delay neurology 2016 experimental therapy Poland 2,7
423 cord tissue spinal muscular atrophy neurology 2016 experimental therapy Poland 3,3
424 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59,6
425 cord tissue spinal muscular atrophy neurology 2016 experimental therapy Poland 34,2
426 cord tissue muscular dystrophy neurology 2016 experimental therapy Poland 30,3
427 cord tissue spinal muscular atrophy neurology 2016 experimental therapy Poland 17,10
428 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 37,11
429 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31,9
430 cord tissue ataxia hereditaria neurology 2016 experimental therapy Poland 69
431 cord tissue muscular dystrophy neurology 2016 experimental therapy Poland 31,9
432 cord tissue no data ophthalmology 2016 experimental therapy Poland 66,1
433 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
434 cord tissue patella cartilage damage orthopedics 2016 experimental therapy Poland 60,8
435 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 10,8
436 cord tissue encephalopathy neurology 2016 experimental therapy Poland 3
437 cord tissue spina bifida neurology 2016 experimental therapy Poland 2,11
438 cord tissue encephalopathy neurology 2016 experimental therapy Poland 4,3
439 cord tissue retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 0.0
440 cord tissue retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59,4
441 cord tissue atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,11
442 cord tissue patella cartilage damage orthopedics 2016 experimental therapy Poland 53
443 cord tissue autism neurology 2016 experimental therapy Poland 24,5
444 cord tissue dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 34, 7
445 cord tissue muscular dystrophy neurology 2016 experimental therapy Poland 32,3
446 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65,9
447 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,7
448 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 71,5
449 cord tissue retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60,7
450 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 1,10
451 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 7,6
452 cord tissue spinal muscular atrophy neurology 2016 experimental therapy Poland 1,10
453 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 29,7
454 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,5
455 cord tissue chronic graft versus host disease hematology 2016 experimental therapy Poland 8/12
456 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
457 cord tissue dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 9,2
458 cord tissue Stargardt's disease ophthalmology 2016 experimental therapy Poland 24,5
459 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,7
460 cord tissue spina bifida neurology 2016 experimental therapy Poland 15,9
461 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 6,8
462 cord tissue autism neurology 2016 experimental therapy Poland 10,3
463 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 16,4
464 cord tissue autism neurology 2016 experimental therapy Poland 6
465 cord tissue spinocerebellar ataxia neurology 2016 experimental therapy Poland 41,8
466 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,9
467 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
468 cord tissue autism neurology 2016 experimental therapy Poland 20,9
469 cord tissue fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5,2
470 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 13,10
471 cord tissue tetraparesis spastica orthopedics 2016 experimental therapy Poland 58,4
472 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,2
473 cord tissue chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54,11
474 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.4
475 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 41.2
476 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72.1
477 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56.8
478 cord tissue spina bifida neurology 2016 experimental therapy Poland 2.1
479 cord tissue tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
480 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 4,1
481 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,1
482 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,3
483 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,10
484 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 0.0
485 cord tissue gangliosidosis t. 1 neurology 2016 experimental therapy Poland 1,4
486 cord tissue epilepsia neurology 2016 experimental therapy Poland 14.9
487 cord tissue epileptic encephalopathy neurology 2016 experimental therapy Poland 3.6
488 cord tissue polineuropathy neurology 2016 experimental therapy Poland 70.8
489 cord tissue diffuse cartilage damage left medial compartment of the knee orthopedics 2016 experimental therapy Poland 50,5
490 cord tissue Stargardt's disease ophthalmology 2016 experimental therapy Poland 37,7
491 cord tissue myopia hyperopia astigmatism abnormal refraction and accommodation optic atrophy ophthalmology 2016 experimental therapy Poland 37,1
492 cord tissue optic neuropathy ophthalmology 2016 experimental therapy Poland 33,5
493 cord tissue epilepsia neurology 2016 experimental therapy Poland 16,2
494 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 3,7
495 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 17,9
496 cord tissue injuries to the spinal nerves neurology 2016 experimental therapy Poland 5/12
497 cord tissue cartilage damage orthopedics 2016 experimental therapy Poland 57,6
498 cord tissue dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 4,8
499 cord tissue muscular dystrophy neurology 2016 experimental therapy Poland 44,7
500 cord tissue dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 10
501 cord tissue cerebral palsy neurology 2016 experimental therapy Poland 4,4
502 cord tissue spina bifida neurology 2016 experimental therapy Poland 4,9
503 cord tissue cerebellar syndrome neurology 2016 experimental therapy Poland 28,6
504 cord tissue neurodevelopmental disorders neurology 2016 experimental therapy Poland 4,5
505 cord tissue tetraparesis orthopedics 2016 experimental therapy Poland 27,2
506 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
507 cord tissue retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 44,8
508 cord tissue degeneration of the cartilage of the knee joint orthopedics 2016 experimental therapy Poland 54,3
509 cord tissue dystrophia progressiva pseudohypertrophica /BMD neurology 2016 experimental therapy Poland 19,2
510 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 15,0
511 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 31,11
512 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 33,4
513 cord tissue endometrial atrophy ginecology 2016 experimental therapy Poland 37,3
514 cord tissue endometrial atrophy ginecology 2016 experimental therapy Poland 39,1
515 cord tissue sclerosis multiplex neurology 2016 experimental therapy Poland 38,4
516 cord tissue spinal cord injury orthopedics 2016 experimental therapy Poland 44,5
517 cord tissue meniscus damage orthopedics 2016 experimental therapy Poland 35,5
518 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
519 cord tissue premature ovarian failure ginecology 2016 experimental therapy Poland 23,4
520 cord tissue premature ovarian failure ginecology 2016 experimental therapy Poland 34,9
521 cord tissue amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,5
522 cord tissue acute graft versus host disease hematology 2015 experimental therapy Poland 1.4
523 cord tissue autism neurology 2015 experimental therapy Poland 5.4
524 cord tissue sclerosis multiplex neurology 2015 experimental therapy Poland 23.2
525 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61.6
526 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61.0
527 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 56
528 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 51
529 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 65
530 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 60
531 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 52
532 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 3,8
533 cord tissue decerebration rigidity neurology 2015 experimental therapy Poland 9,6
534 cord tissue bilateral blindness ophthalmology 2015 experimental therapy Poland 36,10
535 cord tissue acute graft versus host disease hematology 2015 experimental therapy Poland 11/12
536 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 7,1
537 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 15,8
538 cord tissue ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5,1
539 cord tissue encephalopathy neurology 2015 experimental therapy Poland 14,5
540 cord tissue ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7,10
541 cord tissue autism neurology 2015 experimental therapy Poland 3
542 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 7,1
543 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 13,1
544 cord tissue spina bifida neurology 2015 experimental therapy Poland 2,4
545 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59,4
546 cord tissue spinal cord injury orthopedics 2015 experimental therapy Poland 31,2
547 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 5,1
548 cord tissue autism neurology 2015 experimental therapy Poland 12,5
549 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 8,11
550 cord tissue delayed psychomotor development deafness neurology 2015 experimental therapy Poland 3,3
551 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,5
552 cord tissue traumatic encephalopathy neurology 2015 experimental therapy Poland 20,11
553 cord tissue spinal cord injury orthopedics 2015 experimental therapy Poland 18,8
554 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 2,7
555 cord tissue adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 23
556 cord tissue adrenoleukodystrophy neurology 2015 experimental therapy Poland 11,11
557 cord tissue spinal cord injury orthopedics 2015 experimental therapy Poland 40
558 cord tissue spinal cord injury orthopedics 2015 experimental therapy Poland 26,1
559 cord tissue spinal cord injury orthopedics 2015 experimental therapy Poland 37,1
560 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
561 cord tissue spinocerebellar ataxia neurology 2015 experimental therapy Poland 35,6
562 cord tissue spinal muscular atrophy neurology 2015 experimental therapy Poland 11/12
563 cord tissue spinocerebellar ataxia neurology 2015 experimental therapy Poland 44,6
564 cord tissue optic neuropathy ophthalmology 2015 experimental therapy Poland 15,8
565 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
566 cord tissue gonarthrosis orthopedics 2015 experimental therapy Poland 66,2
567 cord tissue iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17,2
568 cord tissue optic neuropathy ophthalmology 2015 experimental therapy Poland 45,10
569 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
570 cord tissue acute graft versus host disease hematology 2015 experimental therapy Poland 51,5
571 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 12,10
572 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26,5
573 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
574 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 4,10
575 cord tissue autism neurology 2015 experimental therapy Poland 6,1
576 cord tissue autism neurology 2015 experimental therapy Poland 4,6
577 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63,11
578 cord tissue spinal cord injury orthopedics 2015 experimental therapy Poland 32,10
579 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 22
580 cord tissue sclerosis multiplex neurology 2015 experimental therapy Poland 33,3
581 cord tissue delayed psychomotor development neurology 2015 experimental therapy Poland 3,6
582 cord tissue spina bifida neurology 2015 experimental therapy Poland 2
583 cord tissue cerebellar ataxia neurology 2015 experimental therapy Poland 18,7
584 cord tissue spinocerebellar ataxia neurology 2015 experimental therapy Poland 24,3
585 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67,6
586 cord tissue autism neurology 2015 experimental therapy Poland 5,6
587 cord tissue polineuropathy neurology 2015 experimental therapy Poland 74,2
588 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37,6
589 cord tissue stroke neurology 2015 experimental therapy Poland 62,8
590 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58,10
591 cord tissue facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30,1
592 cord tissue chronic graft versus host disease hematology 2015 experimental therapy Poland 10
593 cord tissue severe developmental delay neurology 2015 experimental therapy Poland 1,1
594 cord tissue spinal muscular atrophy neurology 2015 experimental therapy Poland 26,2
595 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46,2
596 cord tissue autism neurology 2015 experimental therapy Poland 8,7
597 cord tissue encephalopathy neurology 2015 experimental therapy Poland 8/12
598 cord tissue acute graft versus host disease hematology 2015 experimental therapy Poland 6,6
599 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48,7
600 cord tissue spinal cord injury orthopedics 2015 experimental therapy Poland 21,4
601 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 9,9
602 cord tissue acute graft versus host disease hematology 2015 experimental therapy Poland 13,4
603 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,3
604 cord tissue amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
605 cord tissue intracranial injury neurology 2015 experimental therapy Poland 24,3
606 cord tissue stroke neurology 2015 experimental therapy Poland 54,9
607 cord tissue spinal cord injury orthopedics 2015 experimental therapy Poland 24,7
608 cord tissue gonarthrosis orthopedics 2015 experimental therapy Poland 65,9
609 cord tissue leukodystrophy neurology 2015 experimental therapy Poland 18,8
610 cord tissue spinal cord injury orthopedics 2015 experimental therapy Poland 34,4
611 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 1,6
612 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 14,10
613 cord tissue anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54,10
614 cord tissue cerebral palsy neurology 2015 experimental therapy Poland 16,9
615 cord tissue retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34,5
616 cord tissue cerebellar ataxia neurology 2015 experimental therapy Poland 26,1
617 cord tissue encephalopathy neurology 2015 experimental therapy Poland 11,2
618 cord tissue adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 8,4
619 cord tissue neuropathy neurology 2014 experimental therapy Poland 23.6
620 cord tissue autism neurology 2014 experimental therapy Poland 12,6
621 cord tissue acute graft versus host disease hematology 2014 experimental therapy Poland 6
622 cord tissue central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2,1
623 cord tissue amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 60.1
624 cord tissue amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24.1
625 cord tissue autism neurology 2014 experimental therapy Poland 8.3
626 cord tissue muscular dystrophy neurology 2014 experimental therapy Poland 6.0
627 cord tissue birth asphyxia; retinopathy neurology 2014 experimental therapy Poland 11/12
628 cord tissue cerebral palsy neurology 2014 experimental therapy Poland 4.1
629 cord tissue cerebral palsy neurology 2014 experimental therapy Poland 15.1
630 cord tissue acute graft versus host disease hematology 2013 experimental therapy Poland 18.9
631 cord tissue acute graft versus host disease hematology 2013 experimental therapy Poland 2.1
632 cord tissue acute graft versus host disease hematology 2013 experimental therapy Poland 3.5
633 cord tissue acute myeloid leukemia hematology 2013 experimental therapy Poland 3.5
634 cord tissue chronic graft versus host disease hematology 2013 experimental therapy Poland 18.8
635 cord tissue chronic graft versus host disease hematology 2013 experimental therapy Poland 17.5
636 cord tissue acute graft versus host disease hematology 2012 experimental therapy Poland 19.7
637 cord tissue acute graft versus host disease hematology 2012 experimental therapy Poland 7.1
638 cord tissue acute graft versus host disease hematology 2012 experimental therapy Poland 4.3
639 cord tissue acute graft versus host disease hematology 2011 experimental therapy Poland 17.2
640 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 6.0
641 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 76.0
642 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Turkey 22.0
643 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 2.0
644 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 65.0
645 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Italy 60.0
646 bone marrow myelodysplastic syndrome hematology 2017 standard therapy USA 61.0
647 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Russia 30.0
648 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 4.0
649 bone marrow leukemia hematology 2017 standard therapy USA 40.0
650 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 10.0
651 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 14.0
652 bone marrow severe combined immunodeficiency hematology 2017 standard therapy Turkey 6.0
653 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 55.0
654 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 67.0
655 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 16.0
656 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Lithuania 1.0
657 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 13.0
658 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 38.0
659 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 9.0
660 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Canada 1.0
661 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 59.0
662 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 21.0
663 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 2.0
664 bone marrow hyper IgM syndrome hematology 2017 standard therapy Finland 2.0
665 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Austria 3.0
666 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 1.0
667 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 59.0
668 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 57.0
669 bone marrow pure red cell aplasia hematology 2017 standard therapy USA 5.0
670 bone marrow thalassemia major hematology 2017 standard therapy Turkey 11.0
671 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 10.0
672 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 68.0
673 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 60.0
674 bone marrow Fanconi anaemia hematology 2017 standard therapy Russia 10.0
675 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 10.0
676 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 17.0
677 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 51.0
678 bone marrow juvenile myelomonocytic leukemia hematology 2017 standard therapy Finland 1.0
679 bone marrow acute megakaryocytic leukemia hematology 2017 standard therapy Spain 2.0
680 bone marrow chronic myeloid leukemia hematology 2017 standard therapy USA 51.0
681 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 56.0
682 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 54.0
683 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 24.0
684 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Poland 1.0
685 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 8.0
686 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 9.0
687 bone marrow no data hematology 2017 standard therapy France 32.0
688 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 14.0
689 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 4.0
690 bone marrow Wiskott-Aldrich syndrome hematology 2017 standard therapy Iran 2.0
691 bone marrow T-cell leukemia/lymphoma hematology 2017 standard therapy Iran 18.0
692 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 7.0
693 bone marrow myeloma multiplex hematology 2017 standard therapy Canada 50.0
694 peripheral blood Hurler syndrome hematology 2017 standard therapy United Kingdom 2.0
695 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 44.0
696 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 60.0
697 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 24.0
698 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy United Kingdom 51.0
699 peripheral blood chronic myeloproliferative neoplasm blast crisis hematology 2017 standard therapy Germany 29.0
700 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 43.0
701 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 68.0
702 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy Turkey 29.0
703 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 14.0
704 peripheral blood Niemann–Pick disease hematology 2017 standard therapy Poland 2.0
705 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Iran 17.0
706 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 3.0
707 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 63.0
708 peripheral blood Common variable immunodeficiency relapsed hemophagocytic syndrome hematology 2017 standard therapy Germany 44.0
709 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 65.0
710 peripheral blood myelofibrosis hematology 2017 standard therapy Spain 63.0
711 peripheral blood diffuse large B-cell lymphoma hematology 2017 standard therapy Germany 61.0
712 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 56.0
713 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48.0
714 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Austria 54.0
715 peripheral blood myelofibrosis hematology 2017 standard therapy Denmark 63.0
716 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 47.0
717 peripheral blood no data n/a 2017 standard therapy France 39.0
718 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 54.0
719 peripheral blood Langerhans Lymphohistiocytosis hematology 2017 standard therapy Czech Republic 2.0
720 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 75.0
721 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Slovakia 64.0
722 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Belgium 57.0
723 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 32.0
724 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53.0
725 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 47.0
726 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 43.0
727 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48.0
728 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 56.0
729 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 47.0
730 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 3.0
731 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Spain 20.0
732 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Croatia 64.0
733 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 66.0
734 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 44.0
735 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 46.0
736 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 53.0
737 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 66.0
738 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 75.0
739 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 61.0
740 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 63.0
741 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60.0
742 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 56.0
743 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Lithuania 59.0
744 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 45.0
745 peripheral blood hemophagocytosis hematology 2017 standard therapy USA 52.0
746 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 12.0
747 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 57.0
748 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 19.0
749 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 45.0
750 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 65.0
751 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 64.0
752 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 71.0
753 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 46.0
754 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 55.0
755 peripheral blood no data hematology 2017 standard therapy Poland 39.0
756 peripheral blood aplastic anaemia hematology 2017 standard therapy United Kingdom 23.0
757 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62.0
758 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50.0
759 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 57.0
760 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 58.0
761 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 54.0
762 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 32.0
763 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 75.0
764 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 42.0
765 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63.0
766 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 60.0
767 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 53.0
768 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 67.0
769 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 33.0
770 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 64.0
771 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Germany 56.0
772 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65.0
773 peripheral blood B-cell Chronic lymphoblastic leukemia hematology 2017 standard therapy Germany 48.0
774 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Poland 47.0
775 peripheral blood osteopetrosis hematology 2017 standard therapy Israel 3.0
776 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 56.0
777 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 55.0
778 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 56.0
779 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 65.0
780 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Switzerland 75.0
781 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 69.0
782 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51.0
783 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 30.0
784 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Estonia 67.0
785 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 70.0
786 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 34.0
787 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68.0
788 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7.0
789 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52.0
790 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 59.0
791 peripheral blood myelofibrosis hematology 2017 standard therapy United Kingdom 55.0
792 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 62.0
793 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 59.0
794 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 67.0
795 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 67.0
796 peripheral blood β - Thalassemia Major hematology 2017 standard therapy India 4.0
797 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 48.0
798 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 53.0
799 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55.0
800 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 62.0
801 peripheral blood acute myelogenous leukemia with myelodysplastic syndrome hematology 2017 standard therapy Germany 64.0
802 peripheral blood follicular CA hematology 2017 standard therapy South Africa 42.0
803 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 63.0
804 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 65.0
805 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 35.0
806 peripheral blood other myleofibrosis hematology 2017 standard therapy USA 71.0
807 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 64.0
808 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69.0
809 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 39.0
810 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 54.0
811 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Belgium 38.0
812 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 65.0
813 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 23.0
814 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Slovakia 54.0
815 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 35.0
816 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 46.0
817 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 29.0
818 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 63.0
819 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Czech Republic 12.0
820 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 29.0
821 peripheral blood no data hematology 2017 standard therapy Germany 65.0
822 peripheral blood chronic granulomatous disease hematology 2017 standard therapy Poland 4.0
823 peripheral blood no data hematology 2017 standard therapy Russia 36.0
824 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 58.0
825 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Turkey 54.0
826 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51.0
827 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60.0
828 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 49.0
829 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 38.0
830 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 38.0
831 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 32.0
832 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 36.0
833 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7.0
834 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62.0
835 peripheral blood no data hematology 2017 standard therapy Kanada 32.0
836 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 63.0
837 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 63.0
838 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 4.0
839 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 39.0
840 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 62.0
841 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 65.0
842 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy USA 58.0
843 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 67.0
844 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 58.0
845 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51.0
846 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69.0
847 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 19.0
848 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Switzerland 67.0
849 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 43.0
850 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 68.0
851 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Amsterdam 69.0
852 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Israel 11.0
853 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 4.0
854 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 42.0
855 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7.0
856 peripheral blood no data hematology 2017 standard therapy Poland 58.0
857 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 25.0
858 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 55.0
859 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68.0
860 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 76.0
861 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52.0
862 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 41.0
863 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 49.0
864 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62.0
865 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 2.0
866 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60.0
867 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65.0
868 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51.0
869 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 35.0
870 peripheral blood no data hematology 2017 standard therapy Poland 53.0
871 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 70.0
872 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Germany 64.0
873 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 52.0
874 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy USA 74.0
875 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 30.0
876 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 57.0
877 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 31.0
878 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 64.0
879 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60.0
880 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 49.0
881 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 27.0
882 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53.0
883 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 22.0
884 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 32.0
885 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Germany 44.0
886 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 53.0
887 peripheral blood other malignancy hematology 2017 standard therapy France 59.0
888 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Italy 57.0
889 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 54.0
890 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 61.0
891 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 40.0
892 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Netherlands 53.0
893 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 58.0
894 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy United Kingdom 51.0
895 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68.0
896 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 56.0
897 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62.0
898 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 46.0
899 peripheral blood primary myelofibrosis hematology 2017 standard therapy Germany 29.0
900 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62.0
901 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 59.0
902 bone marrow osteopetrosis metabolic 2016 standard therapy Russia 6.0
903 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Romania 2.0
904 bone marrow T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Italy 4.0
905 bone marrow no data n/a 2016 standard therapy Italy 3.0
906 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64.0
907 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 9.0
908 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Spain 55.0
909 bone marrow Fanconi anaemia hematology 2016 standard therapy Estonia 7.0
910 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 6.0
911 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64.0
912 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 14.0
913 bone marrow biphenotypic leukemia hematology 2016 standard therapy Brazil 27.0
914 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 7.0
915 bone marrow osteopetrosis metabolic 2016 standard therapy Germany 1.0
916 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9.0
917 bone marrow no data n/a 2016 standard therapy Poland 7.0
918 bone marrow Hurler syndrome metabolic 2016 standard therapy United Kingdom 2.0
919 bone marrow  severe combined immunodeficiency hematology 2016 standard therapy Turkey 4.0
920 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Canada 11.0
921 bone marrow myelofibrosis hematology 2016 standard therapy Germany 31.0
922 bone marrow DiGeorge syndrome hematology 2016 standard therapy Netherlands 24.0
923 bone marrow Hodgkin’s lymphoma hematology 2016 standard therapy Italy 17.0
924 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Belarus 12.0
925 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 18.0
926 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Poland 0.6
927 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9.0
928 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology 2016 standard therapy Poland 17.0
929 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Hungary 1.0
930 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 67.0
931 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Spain 56.0
932 bone marrow Fanconi anaemia hematology 2016 standard therapy Netherlands 41.0
933 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy France 5.0
934 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 29.0
935 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 25.0
936 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy New Zealand 1.0
937 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Germany 12.0
938 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5.0
939 bone marrow no data n/a 2016 standard therapy Poland 33.0
940 bone marrow non-Hodgkin lymphoma hematology 2016 standard therapy Italy 46.0
941 bone marrow aplastic anaemia hematology 2016 standard therapy Austria 20.0
942 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Croatia 33.0
943 bone marrow myeloproliferative syndrome hematology 2016 standard therapy Poland 22.0
944 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Ireland 39.0
945 bone marrow Diamond-Balckfan anaemia hematology 2016 standard therapy Germany 2.0
946 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 9.0
947 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 15.0
948 bone marrow juvenile myelomonocytic leukemia hematology 2016 standard therapy Germany 3.0
949 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Finland 45.0
950 bone marrow anaemia hematology 2016 standard therapy Germany 16.0
951 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 6.0
952 bone marrow anaemia hematology 2016 standard therapy Italy 5.0
953 bone marrow high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 18.0
954 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 58.0
955 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 56.0
956 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 60.0
957 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62.0
958 peripheral blood no data n/a 2016 standard therapy Czech Republic 45.0
959 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Slovakia 52.0
960 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 40.0
961 peripheral blood no data n/a 2016 standard therapy Netherlands 70.0
962 peripheral blood no data n/a 2016 standard therapy Poland 43.0
963 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18.0
964 peripheral blood X-linked lymphoproliferative disease hematology 2016 standard therapy Russia 12.0
965 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Sweden 61.0
966 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66.0
967 peripheral blood no data n/a 2016 standard therapy Netherlands 69.0
968 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Columbia 43.0
969 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 64.0
970 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Poland 31.0
971 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 54.0
972 peripheral blood T-cell leukemia/lymphoma hematology 2016 standard therapy Canada 31.0
973 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54.0
974 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 50.0
975 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18.0
976 peripheral blood adrenoleukodystrophy metabolic 2016 standard therapy Poland 1.0
977 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 31.0
978 peripheral blood no data n/a 2016 standard therapy Poland 28.0
979 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Sweden 35.0
980 peripheral blood no data n/a 2016 standard therapy Czech Republic 1.0
981 peripheral blood Wiskott-Aldrich syndrome hematology 2016 standard therapy Poland 1.0
982 peripheral blood no data n/a 2016 standard therapy Belgium 30.0
983 peripheral blood no data n/a 2016 standard therapy Germany 71.0
984 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 46.0
985 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 29.0
986 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Czech Republic 56.0
987 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32.0
988 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 49.0
989 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 50.0
990 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 64.0
991 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 42.0
992 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 13.0
993 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Slovakia 8.0
994 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 46.0
995 peripheral blood refractory anemia with excess blasts hematology 2016 standard therapy United Kingdom 62.0
996 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 40.0
997 peripheral blood myelodysplastic syndrome - RAEB hematology 2016 standard therapy Poland 56.0
998 peripheral blood no data n/a 2016 standard therapy Sweden 58.0
999 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32.0
1000 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 32.0
1001 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66.0
1002 peripheral blood T Cell Lymphoma/ NOS - Not otherwise specified hematology 2016 standard therapy Germany 55.0
1003 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 43.0
1004 peripheral blood no data n/a 2016 standard therapy Czech Republic 59.0
1005 peripheral blood aplastic anaemia hematology 2016 standard therapy United Kingdom 23.0
1006 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 73.0
1007 peripheral blood myelofibrosis hematology 2016 standard therapy Israel 72.0
1008 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Australia 61.0
1009 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 67.0
1010 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Ireland 47.0
1011 peripheral blood no data n/a 2016 standard therapy Germany 17.0
1012 peripheral blood no data n/a 2016 standard therapy France 59.0
1013 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66.0
1014 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Germany 62.0
1015 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 47.0
1016 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 67.0
1017 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Lithuania 15.0
1018 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy United Kingdom 18.0
1019 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 37.0
1020 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 24.0
1021 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Canada 13.0
1022 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 57.0
1023 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 56.0
1024 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 38.0
1025 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 52.0
1026 peripheral blood chronic myelomonocytic leukemia minimal residual disease hematology 2016 standard therapy Poland 50.0
1027 peripheral blood myeloma multiplex hematology 2016 standard therapy Germany 63.0
1028 peripheral blood Fanconi anaemia hematology 2016 standard therapy Estonia 7.0
1029 peripheral blood plasma cell disorder hematology 2016 standard therapy France 47.0
1030 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 35.0
1031 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72.0
1032 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 51.0
1033 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Spain 58.0
1034 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Estonia 62.0
1035 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 46.0
1036 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 20.0
1037 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 51.0
1038 peripheral blood primary Immunodeficiency hematology 2016 standard therapy Russia 5.0
1039 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 62.0
1040 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 69.0
1041 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 51.0
1042 peripheral blood no data n/a 2016 standard therapy Netherlands 58.0
1043 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 38.0
1044 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Lithuania 23.0
1045 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 62.0
1046 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32.0
1047 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 27.0
1048 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 30.0
1049 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 55.0
1050 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 63.0
1051 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 37.0
1052 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66.0
1053 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 38.0
1054 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65.0
1055 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 46.0
1056 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 18.0
1057 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Netherlands 38.0
1058 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 48.0
1059 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 61.0
1060 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 67.0
1061 peripheral blood no data n/a 2016 standard therapy Poland 55.0
1062 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32.0
1063 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Germany 19.0
1064 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 68.0
1065 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 59.0
1066 peripheral blood myelodysplastic syndrome - RCMD hematology 2016 standard therapy Czech Republic 32.0
1067 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 65.0
1068 peripheral blood myelofibrosis hematology 2016 standard therapy Netherlands 66.0
1069 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Switzerland 0.7
1070 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 36.0
1071 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66.0
1072 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Denmark 68.0
1073 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Spain 15.0
1074 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 52.0
1075 peripheral blood chronic myelomonocytic leukaemia hematology 2016 standard therapy Finland 53.0
1076 peripheral blood no data n/a 2016 standard therapy Turkey 4.0
1077 peripheral blood leukemia hematology 2016 standard therapy Lithuania 53.0
1078 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Serbia 21.0
1079 peripheral blood myeloproliferative syndrome hematology 2016 standard therapy Poland 52.0
1080 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 63.0
1081 peripheral blood no data n/a 2016 standard therapy Poland 44.0
1082 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 60.0
1083 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Austria 41.0
1084 peripheral blood primary myelofibrosis hematology 2016 standard therapy Switzerland 67.0
1085 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 20.0
1086 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Brazil 37.0
1087 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 60.0
1088 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 61.0
1089 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 51.0
1090 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 28.0
1091 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 65.0
1092 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 53.0
1093 peripheral blood Lymphoblastic Lymphoma hematology 2016 standard therapy Italy 33.0
1094 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Slovakia 30.0
1095 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 9.0
1096 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 38.0
1097 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 39.0
1098 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 61.0
1099 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy New Zealand 59.0
1100 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62.0
1101 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65.0
1102 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Portugal 41.0
1103 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 59.0
1104 peripheral blood SAA / Amyloidosis hematology 2016 standard therapy United Kingdom 45.0
1105 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Finland 46.0
1106 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 50.0
1107 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 66.0
1108 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 38.0
1109 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 20.0
1110 peripheral blood myelofibrosis hematology 2016 standard therapy France 67.0
1111 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2016 standard therapy Belgium 44.0
1112 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Poland 58.0
1113 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72.0
1114 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 68.0
1115 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 63.0
1116 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 56.0
1117 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54.0
1118 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 24.0
1119 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Greece 9.0
1120 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 40.0
1121 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 15.0
1122 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 37.0
1123 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Russia 44.0
1124 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 59.0
1125 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 32.0
1126 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62.0
1127 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 55.0
1128 peripheral blood composite lymphoma hematology 2016 standard therapy Germany 51.0
1129 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 30.0
1130 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 33.0
1131 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 58.0
1132 peripheral blood high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5.0
1133 peripheral blood acute myelogenous leukemia M2/M4 hematology 2016 standard therapy Germany 59.0
1134 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Netherlands 39.0
1135 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 21.0
1136 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 50.0
1137 peripheral blood plasma cell disorder hematology 2016 standard therapy France 54.0
1138 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 47.0
1139 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Canada 47.0
1140 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 67.0
1141 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62.0
1142 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 63.0
1143 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 19.0
1144 peripheral blood T-cell-prolymphocytic leukemia hematology 2016 standard therapy United Kingdom 61.0
1145 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy USA 69.0
1146 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 35.0
1147 peripheral blood severe aplastic anaemia hematology 2016 standard therapy Russia 18.0
1148 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 66.0
{{$index+1}} {{item.source}} {{item.indication}} {{item.area}} {{item.year}} {{item.therapy}} {{item.country}} {{item.age | number}}